These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38665026)

  • 1. Tropomyosin 2 Regulates Tumor Cell Proliferation, Immune Suppression, and Activation of the JNK Signaling Pathway in Colitis-Associated Cancer (CAC).
    Sun A; Ge J; Ding K; Gao Z; Zhang Y
    Discov Med; 2024 Apr; 36(183):778-787. PubMed ID: 38665026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanic evaluation of Wu-Mei-Pill on colitis-associated colorectal cancer: An integrated transcriptomics, metabolomics, and experimental validation study.
    Cui H; Jin Y; Wang N; Liu H; Shu R; Wang J; Wang X; Jia B; Wang Y; Bian Y; Wen W
    Phytomedicine; 2024 Jun; 128():155509. PubMed ID: 38452403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.
    Li ZW; Sun B; Gong T; Guo S; Zhang J; Wang J; Sugawara A; Jiang M; Yan J; Gurary A; Zheng X; Gao B; Xiao SY; Chen W; Ma C; Farrar C; Zhu C; Chan OTM; Xin C; Winnicki A; Winnicki J; Tang M; Park R; Winnicki M; Diener K; Wang Z; Liu Q; Chu CH; Arter ZL; Yue P; Alpert L; Hui GS; Fei P; Turkson J; Yang W; Wu G; Tao A; Ramos JW; Moisyadi S; Holcombe RF; Jia W; Birnbaumer L; Zhou X; Chu WM
    Gastroenterology; 2019 Jun; 156(8):2297-2312. PubMed ID: 30836096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Banxia Xiexin Decoction inhibiting colitis-associated colorectal cancer infected with Fusobacterium nucleatum by regulating Wnt/β-catenin pathway].
    Jiang YF; Huang YQ; Hu YE; Yang Y; Zheng C; You FM; Zhao ZY
    Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1266-1274. PubMed ID: 38621974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.
    Liu ZY; Zheng M; Li YM; Fan XY; Wang JC; Li ZC; Yang HJ; Yu JM; Cui J; Jiang JL; Tang J; Chen ZN
    Theranostics; 2019; 9(12):3659-3673. PubMed ID: 31281505
    [No Abstract]   [Full Text] [Related]  

  • 7. Wumei Pill Ameliorates AOM/DSS-Induced Colitis-Associated Colon Cancer through Inhibition of Inflammation and Oxidative Stress by Regulating S-Adenosylhomocysteine Hydrolase- (AHCY-) Mediated Hedgehog Signaling in Mice.
    Wang J; Ding K; Wang Y; Yan T; Xu Y; Deng Z; Lin W; Zhang L; Zhu W; Zhao R; Zhou Y; Liu Z
    Oxid Med Cell Longev; 2022; 2022():4061713. PubMed ID: 35927991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30L/CD30 signaling regulates the formation of the tumor immune microenvironment and inhibits intestinal tumor development of colitis-associated colon cancer in mice.
    Wang X; Gao Y; Zhang X; Wang X; Wang B; Meng X; Yoshikai Y; Wang Y; Sun X
    Int Immunopharmacol; 2020 Jul; 84():106531. PubMed ID: 32353687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer.
    Bai B; Wu F; Ying K; Xu Y; Shan L; Lv Y; Gao X; Xu D; Lu J; Xie B
    Theranostics; 2021; 11(13):6225-6239. PubMed ID: 33995655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway.
    Zheng R; Ma J; Wang D; Dong W; Wang S; Liu T; Xie R; Liu L; Wang B; Cao H
    Mediators Inflamm; 2018; 2018():1562010. PubMed ID: 30498394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early administration of Wumei Wan inhibit myeloid-derived suppressor cells via PI3K/Akt pathway and amino acids metabolism to prevent colitis-associated colorectal cancer.
    Lu ZH; Ding Y; Wang YJ; Chen C; Yao XR; Yuan XM; Bu F; Bao H; Dong YW; Zhou Q; Li L; Chen T; Li Y; Zhou JY; Wang Q; Shi GP; Jiang F; Chen YG
    J Ethnopharmacol; 2024 Oct; 333():118260. PubMed ID: 38685367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and Autophagy.
    Sheng YH; Giri R; Davies J; Schreiber V; Alabbas S; Movva R; He Y; Wu A; Hooper J; McWhinney B; Oancea I; Kijanka G; Hasnain S; Lucke AJ; Fairlie DP; McGuckin MA; Florin TH; Begun J
    Cell Mol Gastroenterol Hepatol; 2021; 11(1):33-53. PubMed ID: 32497793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGB1 released from GSDME-mediated pyroptotic epithelial cells participates in the tumorigenesis of colitis-associated colorectal cancer through the ERK1/2 pathway.
    Tan G; Huang C; Chen J; Zhi F
    J Hematol Oncol; 2020 Nov; 13(1):149. PubMed ID: 33160389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ultralow dose of the NADPH oxidase inhibitor diphenyleneiodonium (DPI) is an economical and effective therapeutic agent for the treatment of colitis-associated colorectal cancer.
    Kuai Y; Liu H; Liu D; Liu Y; Sun Y; Xie J; Sun J; Fang Y; Pan H; Han W
    Theranostics; 2020; 10(15):6743-6757. PubMed ID: 32550901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-597-5p inhibits carcinogenesis and macrophage recruitment in colitis-related colorectal cancer via reducing the expression of CXCL5.
    Li S; Yu M; Wang X; Fei B
    Cancer Biol Ther; 2023 Dec; 24(1):2274122. PubMed ID: 37942533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The germ-free mice monocolonization with
    Lee YP; Chiu CC; Lin TJ; Hung SW; Huang WC; Chiu CF; Huang YT; Chen YH; Chen TH; Chuang HL
    Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):207-213. PubMed ID: 30706742
    [No Abstract]   [Full Text] [Related]  

  • 17. MUC1-mediated Macrophage Activation Promotes Colitis-associated Colorectal Cancer via Activating the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Axis.
    Sheng YH; Davies JM; Wang R; Wong KY; Giri R; Yang Y; Begun J; Florin TH; Hasnain SZ; McGuckin MA
    Cell Mol Gastroenterol Hepatol; 2022; 14(4):789-811. PubMed ID: 35809803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice.
    Liu M; Xie W; Wan X; Deng T
    Int Immunopharmacol; 2020 Nov; 88():106862. PubMed ID: 32771947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice.
    Kim SW; Kim HM; Yang KM; Kim SA; Kim SK; An MJ; Park JJ; Lee SK; Kim TI; Kim WH; Cheon JH
    Inflamm Bowel Dis; 2010 Sep; 16(9):1514-25. PubMed ID: 20310012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Obesity Drug Orlistat Alleviates Western-Diet-Driven Colitis-Associated Colon Cancer via Inhibition of STAT3 and NF-κB-Mediated Signaling.
    Jin BR; Kim HJ; Sim SA; Lee M; An HJ
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.